Genix Pharmaceuticals Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GENPF research report →
Price Chart
About the company
Genix Pharmaceuticals Corporation, established in 1993 and headquartered in Vancouver, Canada, is actively involved in the creation, production, licensing, and distribution of various life science products. The company's primary focus in the Canadian market is on nutraceuticals and pharmaceuticals. Their product pipeline features several key developments: Flu-X: An herbal treatment available as an oral solution or spray, targeting viral infections, influenza, and coronaviruses responsible for common colds.
- CEO
- Sina Salehi Pirooz
- IPO
- 2020
- Employees
- 4,000
- HQ
- Vancouver, BC, CA
Get TickerSpark's AI analysis on GENPF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $844.89K
- P/E
- -5.00
- PEG
- 0.01
- P/S
- 0.00
- P/B
- -0.75
- EV/EBITDA
- -16.64
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 19.27%
- ROIC
- 14.86%
Latest fiscal year · YoY change
- Revenue
- $0-100.0%
- Gross Profit
- $-1,131-187.2%
- Op Income
- $-153,262.3
- Net Income
- $-335,009-357.7%
- EPS
- $-0.01-366.7%
- OCF Growth
- +33.8%
- FCF Growth
- +33.8%
- 52W High
- $0.04
- 52W Low
- $0.01
- 50D MA
- $0.01
- 200D MA
- $0.02
- Beta
- 0.40
- RSI (14)
- 31
- Avg Volume
- 163
No earnings-call transcripts are available for GENPF yet.
- Free Float
- 84.3%
- Shares Outstanding
- 61.22M
- Float Shares
- 51.60M
Our GENPF coverage
Recent articles, reports, and earnings notes.
No research on GENPF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GENPF report →Genix Pharmaceuticals Announces Change To CFO
thenewswire.com · May 5
Genix Pharmaceuticals Issues Clarification to Previously Announced Private Placement Terms
newsfilecorp.com · Oct 7
Genix Pharmaceuticals Closes Private Placement
newsfilecorp.com · Sep 4
Genix Announces TSX-V Approval of Warrant Amendments
newsfilecorp.com · Feb 6
Genix Announces Warrant Repricing and Seeks Extension
newsfilecorp.com · Jan 18
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.